Ken Berlack
In France, the INCa defined ‘ultrapriority’ patients with cancer for vaccination against SARS-CoV-2 as (1) patients with curative intent treatment excluding basal cell skin carcinoma, (2) patients on palliative first- or second-line chemotherapy and (3) patients receiving radiotherapy for a ...
We did a phase 3, open-label, multicentre, randomised trial at 35 hospitals in France. Eligible patients were adults aged 18–75 years and had newly diagnosed, biopsy-proven, rectal adenocarcinoma staged cT3 or cT4 M0, with a WHO performance status of 0–1. Patients were randomly assigned...
We evaluated the benefit of adding docetaxel-5-fluorouracil (D-5FU) regimen after preoperative dose-intense (DI) epirubicin-cyclophosphamide (EC) and locoregional treatment in IBC patients.PEGASE 07 was a national randomized phase III open-label study involving 14 hospitals in France. Women with ...
Institute Claude Regaud, Institut Universitaire du Cancer (IUCT)–Oncopole, F-31059 Toulouse, France 8 Centre de Recherches en Cancérologie de Toulouse (CRCT), INSERM UMR1037, University Paul Sabatier, Toulouse III, F-31037 Toulouse, France ...